PMS2 and Lynch syndrome: Due to this milder phenotype, routine screening for colorectal cancer in PMS2‐associated Lynch syndrome is recommended from the age of 35 years, in contrast with MLH1/MSH2 mutations where screening is advised from the age of 25 years [43].